Guarino SH, Williams KD, Caplan RJ, Fawcett M, Lanzkron S J Clin Transl Sci 2023 ;7(1):e152 PMID: 37528938 Abstract We used Cerner Real-World Data™, representing hospital admission records from 2020, to examine patients with co-occurring sickle cell disease and COVID-19 by discharge disposition grouped as death/hospice versus transfers to other facilities, returned home, or left
Pachter LM J Dev Behav Pediatr 2020 Sep;41(7):511-512 PMID: 32833871 Abstract No abstract available.
Guarino S, Wright CS, Pachter LM, Lanzkron SM Dela J Public Health 2022 Oct;8(4):8-11 PMID: 36340952 Abstract No abstract available.
Pernell B, Nagalapuram V, Lebensburger J, Lin CP, Baskin ML, Pachter LM Pediatr Blood Cancer 2022 Mar;69(3):e29494 PMID: 34913574 Abstract BACKGROUND”>Adverse childhood experiences (ACEs) are linked to poor health outcomes; however, the relationship between ACEs and health outcomes among children and adolescents with sickle cell disease (SCD) has limited documentation in the published literature.</Abstr: Adverse
Wright JL, Jarvis JN, Pachter LM, Walker-Harding LR Pediatr Res 2020 Nov;88(5):696-698 PMID: 32916682 Abstract No abstract available.
Rohde JF, Canter K, Houff M, Bodt B, Pachter LM, Di Guglielmo MD, Goyal N J Child Health Care 2023 Apr;():13674935231168676 PMID: 37043307 Abstract Opioid use disorder (OUD) during pregnancy has risen in the U.S. over the past two decades, resulting in a growing number of children with intrauterine opioid exposure (IOE). Limited research exists
Abatemarco DJ, Kairys SW, Gubernick RS, Kairys JA Jt Comm J Qual Patient Saf 2008 Feb;34(2):106-15 PMID: 18351195 Abstract BACKGROUND: Behavioral, developmental, and psychosocial problems (“new morbidities”) significantly affect the well-being of children ages 0-3 years. Practices generally fail to deliver consistent anticipatory guidance or counseling to parents. A multifaceted intervention was designed to increase
Williams KD, Jurkovitz CT, Papas MA, Muther AK, Anderson SL, Anderson TL JMIR Form Res 2022 Aug;6(8):e39772 PMID: 35973033 Abstract BACKGROUND: The emergence of COVID-19 exacerbated the existing epidemic of opioid use disorder (OUD) across the United States due to the disruption of in-person treatment and support services. Increased use of technology including telehealth and
Williams KD, Wilson BL, Jurkovitz CT, Melson JA, Reitz JA, Pal CK, Hausman SP, Booker E, Lang LJ, Horton TL Implement Res Pract ;3(): PMID: 35846074 Abstract Background: Opioid-related inpatient hospital stays are increasing at alarming rates. Unidentified and poorly treated opioid withdrawal may be associated with inpatients leaving against medical advice and increased health
McIntire RK, Brooks M, Siegel SD, , Papas M Dela J Public Health 2019 Feb;5(1):26-28 PMID: 34467011 Abstract Public health decision-makers need to consider geographic differences in rates of chronic disease risk factors and outcomes in order to focus intervention efforts on populations exhibiting the greatest burden of disease. Increasingly, public health agencies are using